November 2022
Xocova® Approved in Japan to treat SARS-CoV-2 Infection
Shionogi & Co., Ltd. announced that Xocova® (Ensitrelvir Fumaric Acid), a novel anti-SARS-CoV-2 drug for COVID-19 obtained emergency regulatory approval from the Ministry of Health, Labour and Welfare (MHLW) in Japan for the indication of SARS-CoV-2 infection. This approval was granted under the emergency regulatory approval system provided for in Article 14-2-2 of the Pharmaceuticals and […]
hinotori™ in Gastroenterology and Gynecology
Medicaroid announced it received the regulatory approval form the Japanese Ministry of Health, Labor and Welfare (MHLW) for the use of hitotori Surgical Robot System in gastroenterology and gynecology on October 11. Medicaroid also announced that the HF Series Clip Applier (in 3 types: S, ML, and L), a dedicated instrument for the hinotori, was […]
US-Japan Healthcare Being Innovation Forum 2022
On November 2, the U.S.-Japan Well-Being Innovation Forum 2022 was held on Awaji Island. This forum originated from a forum organized by US-Japan Medtech Frontiers, which has been introducing the Silicon Valley ecosystem and the startups born there to the Japanese public since 2014. This year's event is part of the US-Japan Healthcare Connection program […]